Publications by authors named "Troy Luster"

Claim this Profile
S
Synthesis of diphenyl-(2-thienyl)phosphine, its chalcogenide derivatives and a series of novel complexes of lanthanide nitrates and triflates.
Troy Luster, Hannah J Van de Roovaart, Kyle J Korman, Georgia G Sands, Kylie M Dunn

Dalton Trans· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic CRISPR Screens Identify as a Therapeutic Vulnerability in Non-Small Cell Lung Cancer.
Fei Li, Wai-Lung Ng, Troy A Luster, Hai Hu, Vladislav O Sviderskiy

Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Epigenetic CRISPR Screen Identifies as an Immunotherapeutic Target in -Mutant Lung Adenocarcinoma.
Fei Li, Qingyuan Huang, Troy A Luster, Hai Hu, Hua Zhang

Cancer Discov· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing.
Patrick H Lizotte, Ruey-Long Hong, Troy A Luster, Megan E Cavanaugh, Luke J Taus

Cancer Immunol Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo.
Troy A Luster, Ipsita Mukherjee, Jeffrey A Carrell, Yun Hee Cho, Jeffrey Gill

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel.
Khalid A Mohamedali, Gang Niu, Troy A Luster, Philip E Thorpe, Haokao Gao

Biochem Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Necrosis Factor-related apoptosis-inducing ligand (TRAIL) Receptor-1 and Receptor-2 agonists for cancer therapy.
Norma Lynn Fox, Robin Humphreys, Troy A Luster, Jerry Klein, Gilles Gallant

Expert Opin Biol Ther· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma.
Jin He, Yi Yin, Troy A Luster, Linda Watkins, Philip E Thorpe

Clin Cancer Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib.
Troy A Luster, Jeffrey A Carrell, Kathy McCormick, David Sun, Robin Humphreys

Mol Cancer Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids.
Jin He, Troy A Luster, Philip E Thorpe

Clin Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells.
Troy A Luster, Jin He, Xianming Huang, Sourindra N Maiti, Alan J Schroit

J Biol Chem· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice.
Adam W Beck, Troy A Luster, Andrew F Miller, Shane E Holloway, Chris R Conner

Int J Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distal enhancer of the mouse FGF-4 gene and its human counterpart exhibit differential activity: critical role of a GT box.
Brian Boer, Troy A Luster, Cory Bernadt, Angie Rizzino

Mol Reprod Dev· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.
Sophia Ran, Khalid A Mohamedali, Troy A Luster, Philip E Thorpe, Michael G Rosenblum

Neoplasia· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of the FGF-4 gene by a complex distal enhancer that functions in part as an enhanceosome.
Troy A Luster, Angie Rizzino

Gene· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of B-Myb on gene transcription: phosphorylation-dependent activity ans acetylation by p300.
Lance R Johnson, Teresa K Johnson, Michelle Desler, Troy A Luster, Tamara Nowling

J Biol Chem· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis